Epilepsy in Children: Individual Symptomatic (Structural) Forms
Abstract
Epilepsy is a chronic disease of the central nervous system. Most studies have shown that the peak incidence occurs in children under 15 years of age, especially in the first year of life. The diagnosis of epilepsy, unlike other chronic diseases, imposes a sociocultural and moral burden on patients and their parents. Data on the prevalence of this disease in children in different countries are presented. The mortality rate in children with epilepsy is 2-4 times higher than in the rest of the population. A new classification of epilepsy in 2017 by distribution depending on the etiologic factor is demonstrated, which is important for choosing the tactics of the course. Epileptic seizures in patients with infectious diseases of the brain, ischemic or hemorrhagic stroke, after traumatic brain injury are described in more detail, and the features of acute attacks, as well as late epileptic seizures in these diseases are presented. Recommendations on antiepileptic drugs as initial monotherapy in children with focal seizures and depending on the underlying process causing the development of a particular symptomatic (structural) form of epilepsy are highlighted.
References
1. Gekht A.B. Beginning and termination of antiepileptic therapy in adults. Diagnostics, treatment, social aspects of epilepsy: Proc. Int. Conf. St. Petersburg, 2006. Pp. 126-134.
2. Gromov S.A. Controlled epilepsy. Clinic, diagnosis, treatment. St. Petersburg: “IIC Baltika”, 2004. 302 p.
3. Genton P. Paradoxical worsening of seizures in patients with epilepsy. Epilepsy – diagnostics, treatment, social aspects: int. conf. M., 2005. pp. 139-142.
4. Zenkov L.R. Clinical electroencephalography with elements of epileptology. Moscow: MEDpress-inform, 2002. 368 p.
5. Zenkov L.R. Pharmacoresistant epilepsies. Moscow: “MEDpressinform”, 2003. 207 p.
6. Karlov V.A. Convulsive epileptic status. Moscow: Medpress, 2003.168 p.
7. Litvinovich E.F., Savchenko A.Yu., Pospolit A.V. Modern aspects of pharmacotherapy of epileptic status. Clinical epileptology 2007; 1: 28-32.
8. Mironov M.B., Mukhin K.Yu., Petruhin A.S. Monitoring the effectiveness of treatment of patients with juvenile forms of idiopathic generalized epilepsy and the state of "pseudoremission". Journal of Neurology and Psychiatry named after S.S. Korsakov 2005; Vol. 105 (8): 24-28.
9. Mikhailov V. A. Epilepsy: stigmatization, quality of life and rehabilitation of patients. Neurological Bulletin 2007; issue 3: 135-136.
10. Nikitina O.V. Medical and social aspects of epilepsy in adolescents: theses of the anniversary conference with international participation. Egypt, 2008. P.43.
11. Petrukhin A.S., Pylaeva O.A., Voronkova K.V. Aggravation of epileptic seizures under the influence of antiepileptic drugs. S.S. Korsakov Journal of Neurology and Psychiatry 2005;105: 66-70.
12. Shershever A.S., Sorokina E.V., Sulimov A.V. Remission failure in patients with epilepsy when switching from original antiepileptic drugs to generics. Clinical epileptology 2007; 1: 10-12.
13. Beghi E. Efficacy and tolerance of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 2004; Vol.3: 618-621.
14. Guerrini R., Arzimanoglou A., Brauwer O. Rationale for treating epilepsy in Children. Epileptic Disorders 2002; Vol.4: l.2: 9-21.
15. Holloway R., French J., Kanner A. Efficacy and tolerance of the new antiepileptic drugs: Treatment of new onset epilepsy. Neurology 2005; Vol.64: 172-174.
16. Luscher W., Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J. of pharmacology and experimental therapeutics 2002; Vol. 301: 7-14.
17. Pompili M., Girard P., Roberto A. Suicide in the epilepsies: a metaanalytic investigation of 29 cohorts. Epilepsy Behav. 2005; Vol. 7: 305-310.
18. Schmidt D., Löscher W. Uncontrolled epilepsy following discontinuation of antiepileptic drugs in seizure free patients: a review of current clinical experience. Acta Neurol Scand. 2005; Vol. 111(5): 291-300.
19. Specchio L., Beghi E. Should antiepileptic drugs be withdrawn in seizure-free patients. CNS Drugs. 2004; Vol. 18(4);: 201-212.
